Literature DB >> 3150694

The prophylactic efficacy of fluoxetine in unipolar depression.

S A Montgomery1, H Dufour, S Brion, J Gailledreau, X Laqueille, G Ferrey, P Moron, N Parant-Lucena, L Singer, J M Danion.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3150694

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN： 0960-5371


× No keyword cloud information.
  31 in total

Review 1.  [Therapy resistance to antidepressants. Definition, prevalence, predictors, and interventional possibilities].

Authors:  H-J Möller
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

2.  Long-term treatment with moclobemide. An open-label, non-comparative, multiple-distributed study in patients with a major depressive episode as defined by DSM-III.

Authors:  E Moll; M Stabl; R Wegscheider; R Amrein
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 3.  Continuation and maintenance therapy with antidepressive agents. An overview of research.

Authors:  A J Loonen; G J Zwanikken
Journal:  Pharm Weekbl Sci       Date:  1990-08-24

4.  Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.

Authors:  Robin B Jarrett; Michael E Thase
Journal:  Contemp Clin Trials       Date:  2010-05-06       Impact factor: 2.226

5.  Selective serotonin reuptake inhibitors.

Authors:  J G Edwards
Journal:  BMJ       Date:  1992-06-27

Review 6.  Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology.

Authors:  M Hotopf; G Lewis; C Normand
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

Review 7.  Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.

Authors:  H J Möller; H P Volz
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

Review 8.  A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents.

Authors:  J Renaud; D Axelson; B Birmaher
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

Review 9.  Continuation treatment of major depressive disorder: is there a case for duloxetine?

Authors:  Trevor R Norman; James S Olver
Journal:  Drug Des Devel Ther       Date:  2010-02-18       Impact factor: 4.162

Review 10.  Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacology.

Authors:  André R Brunoni; Laura Tadini; Felipe Fregni
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.